Bullboard - Stock Discussion Forum TRANSITION THERAPEUTICS INC. T.TTH

Healthcare Biotechnology

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."

Add To Watchlist

TSX:TTH - Post Discussion

TRANSITION THERAPEUTICS INC. > interesting times ahead for T.TTH. uptrend will start

View:

Post by testfreak on Jun 27, 2015 12:39am

interesting times ahead for T.TTH. uptrend will start

Lots going on. Several trials underway

Transition Therapeutics licenses androgen receptor modulator from Lilly

May. 6, 2015 10:18 AM• SA Editor Douglas W. House

Transition Therapeutics (TTHI+0.7%) secures exclusive worldwide rights to TT701, a small molecule drug candidate from Eli Lilly (LLY+0.1%). TT701 is a selective androgen receptor modulator that demonstrated a positive effect on lean body mass and muscle strength in a Phase 2 study. The completed 12-week, 350-subject trial also demonstrated significant fat mass reduction with no major change in prostate specific antigen (PSA) levels.
Transition is assessing multiple development paths for TT701, including androgen deficiency.
Under the terms of the agreement, Lilly will receive contingent upfront consideration of $1M, up to $100M in commercial milestones and mid-single digit sales-based royalties.

328